{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:35:46Z","timestamp":1783038946910,"version":"3.54.6"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","award":["813781"],"award-info":[{"award-number":["813781"]}],"id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0070455"],"award-info":[{"award-number":["NNF21OC0070455"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF22OC0081058"],"award-info":[{"award-number":["NNF22OC0081058"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF20CC0035580"],"award-info":[{"award-number":["NNF20CC0035580"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["334814"],"award-info":[{"award-number":["334814"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["321716"],"award-info":[{"award-number":["321716"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["339184"],"award-info":[{"award-number":["339184"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"It\u00e4-Suomen Yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.molmet.2023.101823","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T00:32:06Z","timestamp":1697243526000},"page":"101823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model"],"prefix":"10.1016","volume":"78","author":[{"given":"Valeria","family":"Iannone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrin Farizah","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnson","family":"Lok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0219-1827","authenticated-orcid":false,"given":"Carlos","family":"G\u00f3mez-Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D'Auria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Vazquez-Uribe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels Holger","family":"Vaaben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareike","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santtu","family":"Mikkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Vaittinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Tikkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Kettunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Kl\u00e5vus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratika","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"Kaminska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Pihlajamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kati","family":"Hanhineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"El-Nezami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Otto Alexander","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjukka","family":"Kolehmainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic fatty liver disease: pathology and pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"7","key":"10.1016\/j.molmet.2023.101823_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","article-title":"A\u00a0vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.molmet.2023.101823_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"6","key":"10.1016\/j.molmet.2023.101823_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.molmet.2023.101823_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1194\/jlr.R066357","article-title":"Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis","volume":"57","author":"Hirsova","year":"2016","journal-title":"J\u00a0Lipid Res"},{"issue":"3","key":"10.1016\/j.molmet.2023.101823_bib7","doi-asserted-by":"crossref","first-page":"G440","DOI":"10.1152\/ajpgi.00322.2009","article-title":"The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance","volume":"298","author":"Schreuder","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"10.1016\/j.molmet.2023.101823_bib9","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib10","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1158\/0008-5472.CAN-14-0208","article-title":"Separating tumorigenicity from bile acid regulatory activity for endocrine hormone FGF19","volume":"74","author":"Zhou","year":"2014","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.molmet.2023.101823_bib11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/hep4.1108","article-title":"Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice: Zhou et\u00a0al","volume":"1","author":"Zhou","year":"2017","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2020.08.004","article-title":"Efficacy and safety of aldafermin, an engineered FGF19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis","volume":"160","author":"Harrison","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.molmet.2023.101823_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2020.07.007","article-title":"Microbiota and fatty liver disease\u2014the known, the unknown, and the future","volume":"28","author":"Lang","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.molmet.2023.101823_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.molmet.2023.101823_bib15","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3390\/foods10081719","article-title":"Probiotics and prebiotics as a strategy for non-alcoholic fatty liver disease, a narrative review","volume":"10","author":"Castillo","year":"2021","journal-title":"Foods"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib16","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12967-022-03543-z","article-title":"Modulation of hepatic stellate cells by Mutaflor\u00ae probiotic in non-alcoholic fatty liver disease management","volume":"20","author":"Hany","year":"2022","journal-title":"J\u00a0Transl Med"},{"issue":"2","key":"10.1016\/j.molmet.2023.101823_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/oby.22700","article-title":"Genetically engineered Escherichia coli Nissle 1917 secreting GLP-1 analog exhibits potential antiobesity effect in high-fat diet-induced obesity mice","volume":"28","author":"Ma","year":"2020","journal-title":"Obesity"},{"issue":"8","key":"10.1016\/j.molmet.2023.101823_bib18","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1172\/JCI72517","article-title":"Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity","volume":"124","author":"Chen","year":"2014","journal-title":"J\u00a0Clin Investig"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib19","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/acssynbio.1c00325","article-title":"Escherichia coli promoters with consistent expression throughout the murine gut","volume":"10","author":"Armetta","year":"2021","journal-title":"ACS Synth Biol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.molmet.2023.101823_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2023.109307","article-title":"Associations of altered hepatic gene expression in American lifestyle-induced obesity syndrome diet-fed mice with metabolic changes during NAFLD development and progression","author":"Iannone","year":"2023","journal-title":"J\u00a0Nutr Biochem"},{"issue":"5","key":"10.1016\/j.molmet.2023.101823_bib22","doi-asserted-by":"crossref","first-page":"G987","DOI":"10.1152\/ajpgi.90272.2008","article-title":"Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent","volume":"295","author":"Tetri","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"15","key":"10.1016\/j.molmet.2023.101823_bib23","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/bioinformatics\/btx180","article-title":"Trainable Weka Segmentation: a machine learning tool for microscopy pixel classification","volume":"33","author":"Arganda-Carreras","year":"2017","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"8","key":"10.1016\/j.molmet.2023.101823_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkz114","article-title":"The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.molmet.2023.101823_bib26","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib28","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/metabo10040135","article-title":"\u201cNotame\u201d: workflow for non-targeted LC\u2013MS metabolic profiling","volume":"10","author":"Kl\u00e5vus","year":"2020","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.molmet.2023.101823_bib30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76603-3","article-title":"VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots","volume":"10","author":"Goedhart","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2015.06.042","article-title":"Liver X receptors at the intersection of lipid metabolism and atherogenesis","volume":"242","author":"Lee","year":"2015","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib33","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1007\/s10620-014-3289-x","article-title":"Expression of liver X receptor correlates with intrahepatic inflammation and fibrosis in patients with nonalcoholic fatty liver disease","volume":"59","author":"Ahn","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.molmet.2023.101823_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2019.09.006","article-title":"The anti-obesity effect of FGF19 does not require UCP1-dependent thermogenesis","volume":"30","author":"Antonellis","year":"2019","journal-title":"Mol Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/antiox11010091","article-title":"Oxidative stress is a key modulator in the development of nonalcoholic fatty liver disease","volume":"11","author":"Ma","year":"2021","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/biomedicines9040365","article-title":"Hepatic stellate cell activation and inactivation in NASH-fibrosis\u2014roles as putative treatment targets?","volume":"9","author":"Zisser","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib37","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/jcmm.13501","article-title":"Elevated mitochondrial activity distinguishes fibrogenic hepatic stellate cells and sensitizes for selective inhibition by mitotropic doxorubicin","volume":"22","author":"Gajendiran","year":"2018","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/db12-0466","article-title":"Acylcarnitines","volume":"62","author":"Schooneman","year":"2013","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47216-2","article-title":"Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma","volume":"9","author":"Enooku","year":"2019","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jhep.2015.11.019","article-title":"Ammonia produces pathological changes in human hepatic stellate cells and is a target for therapy of portal hypertension","volume":"64","author":"Jalan","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib41","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jhep.2018.06.023","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","volume":"69","author":"De Chiara","year":"2018","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17370-6","article-title":"The transcriptomic signature of disease development and progression of nonalcoholic fatty liver disease","volume":"7","author":"Cazanave","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.molmet.2023.101823_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/abbi.2000.1829","article-title":"Mitochondrial adaptations to obesity-related oxidant stress","volume":"378","author":"Yang","year":"2000","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.molmet.2023.101823_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2020.09.037","article-title":"Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis","volume":"74","author":"Mohs","year":"2021","journal-title":"J\u00a0Hepatol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib45","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1038\/oby.2011.298","article-title":"Glutathione depletion prevents diet-induced obesity and enhances insulin sensitivity","volume":"19","author":"Findeisen","year":"2011","journal-title":"Obesity"},{"issue":"9","key":"10.1016\/j.molmet.2023.101823_bib46","article-title":"Tryptophan predicts the risk for future type 2 diabetes","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib47","doi-asserted-by":"crossref","first-page":"E311","DOI":"10.1152\/ajpendo.00161.2015","article-title":"Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease","volume":"309","author":"Sunny","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"40","key":"10.1016\/j.molmet.2023.101823_bib48","doi-asserted-by":"crossref","first-page":"34800","DOI":"10.1074\/jbc.M111.235473","article-title":"l-Tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin","volume":"286","author":"Osawa","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.molmet.2023.101823_bib49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/liv.14743","article-title":"Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids","volume":"41","author":"Mello","year":"2021","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.molmet.2023.101823_bib50","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00726-014-1894-9","article-title":"Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease","volume":"47","author":"Lake","year":"2015","journal-title":"Amino Acids"},{"issue":"9","key":"10.1016\/j.molmet.2023.101823_bib51","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-007-0738-5","article-title":"Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice","volume":"50","author":"Toye","year":"2007","journal-title":"Diabetologia"},{"issue":"17","key":"10.1016\/j.molmet.2023.101823_bib52","doi-asserted-by":"crossref","first-page":"21309","DOI":"10.18632\/aging.203460","article-title":"Activation of the gut microbiota-kynurenine-liver axis contributes to the development of nonalcoholic hepatic steatosis in nondiabetic adults","volume":"13","author":"Sui","year":"2021","journal-title":"Aging"},{"issue":"2","key":"10.1016\/j.molmet.2023.101823_bib53","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/oby.23065","article-title":"Kynurenine-induced aryl hydrocarbon receptor signaling in mice causes body mass gain, liver steatosis, and hyperglycemia","volume":"29","author":"Rojas","year":"2021","journal-title":"Obesity"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib54","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.3390\/nu13124452","article-title":"Serum levels of plasmalogens and fatty acid metabolites associate with retinal microangiopathy in participants from the Finnish diabetes prevention study","volume":"13","author":"de Mello","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.molmet.2023.101823_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.618037","article-title":"Emodin improves glucose and lipid metabolism disorders in obese mice via activating Brown adipose tissue and inducing browning of white adipose tissue","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.molmet.2023.101823_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db11-0649","article-title":"The l-\u03b1-Lysophosphatidylinositol\/GPR55 system and its potential role in human obesity","volume":"61","author":"Moreno-Navarrete","year":"2012","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.molmet.2023.101823_bib57","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/jat.4324","article-title":"Phosphatidylcholine (18:0\/20:4), a potential biomarker to predict ethionamide-induced hepatic steatosis in rats","volume":"42","author":"Muta","year":"2022","journal-title":"J\u00a0Appl Toxicol"},{"issue":"12","key":"10.1016\/j.molmet.2023.101823_bib58","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.3390\/cells8121640","article-title":"The effect of fibroblast growth factor 15 signaling in non-steatotic and steatotic liver transplantation from cardiocirculatory death","volume":"8","author":"Avalos-de Le\u00f3n","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.molmet.2023.101823_bib59","series-title":"Hormone assays in biological fluids","first-page":"53","article-title":"Gas chromatography-mass spectrometry","author":"Honour","year":"2006"},{"issue":"1","key":"10.1016\/j.molmet.2023.101823_bib60","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877823001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:49:04Z","timestamp":1777625344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877823001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":60,"alternative-id":["S2212877823001576"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101823","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2023.101823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101823"}}